Falk Heidenreich Selected Research

Graft vs Host Disease (Graft-Versus-Host Disease)

1/2024	Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight.
1/2019	T-cell receptor-α repertoire of CD8+ T cells following allogeneic stem cell transplantation using next-generation sequencing.
5/2007	Alemtuzumab depletes dendritic cells more effectively in blood than in skin: a pilot study in patients with chronic lymphocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Falk Heidenreich Research Topics

Disease

3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2024 - 05/2007
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 11/2016
3	Leukemia 11/2023 - 11/2016
2	COVID-19 04/2021 - 01/2021
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2016 - 05/2007
1	Body Weight (Weight, Body) 01/2021
1	Cytomegalovirus Infections (Inclusion Disease) 01/2019
1	Opportunistic Infections (Opportunistic Infection) 01/2019
1	Neoplasms (Cancer) 02/2018
1	Wilms Tumor (Wilm's Tumor) 11/2016
1	Hyperglycemia 08/2011
1	Male Infertility (Male Sterility) 11/2009
1	Obesity 11/2009
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2009

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 02/2018 - 11/2009
3	ProteomeIBA 02/2018 - 11/2009
2	Peptides (Polypeptides)IBA 01/2021 - 11/2009
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2024
1	Calcineurin InhibitorsIBA 01/2024
1	LigandsIBA 11/2023
1	KIR ReceptorsIBA 11/2023
1	CC ChemokinesIBA 04/2021
1	HLA-A Antigens (HLA-A)IBA 01/2021
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	plerixafor FDA Link 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019
1	EpitopesIBA 02/2018
1	AntigensIBA 11/2016
1	Myeloblastin (Proteinase 3)IBA 11/2016
1	FibromodulinIBA 11/2016
1	Hyaluronic Acid (Hyaluronan)IBA 11/2016
1	SurvivinIBA 11/2016
1	AcidsIBA 11/2016
1	NucleophosminIBA 11/2016
1	Sperm ProteinsIBA 11/2009
1	Alemtuzumab (Campath)FDA Link 05/2007

Therapy/Procedure

2	Stem Cell Transplantation 01/2019 - 11/2016
2	Hematopoietic Stem Cell Transplantation 11/2016 - 05/2007
1	Blood Component Removal (Apheresis) 01/2021
1	Donor Selection 01/2020
1	Transplantation 01/2019
1	Immunotherapy 02/2018
1	Therapeutics 11/2009